Promises and challenges of cell-based therapies to promote lung regeneration in idiopathic pulmonary fibrosis

HIGHLIGHTS

• who: Alejandro Egea-Zorrilla et al. from the Institute for Lung Health (ILH), Department of Internal Medicine, Justus-Liebig University, Universities of , Giessen, Germany have published the research: Promises and Challenges of Cell-Based Therapies to Promote Lung Regeneration in Idiopathic Pulmonary Fibrosis, in the Journal: Cells 2022, 2595 of /2022/
• what: In this review, the authors aim to 3 of 29 summarize the most recent findings in the field, from cellular mechanisms implicated in lung regeneration to the latest cell-based therapies for the treatment of IPF. Although this study shows that the administration . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.